Follow
Expanded Access
Expanded access, also known as compassionate use, provides treatment options for patients with life-threatening diseases. When a patient's condition is so serious that no therapeutic options are available and the patient is not eligible for any clinical trials, expanded access allows the patient to qualify for investigational products, such as drugs or medical devices, which are not otherwise approved for use.
What's Popular in Expanded Access
-
FEB 22, 2024Immunology
The US Food and Drug Administration (FDA) recently approved a tumor-infiltrating lymphocyte (TIL) therapy referred to as ...Written By: Brian G. MorrealeJAN 15, 2024Cancer
The 2014 passage of the Patient Protection and Affordable Care Act (ACA) allowed states to expand Medicaid benefits by m ...Written By: Katie KokolusJAN 08, 2024Cancer
A recent study published in JAMA Network Open has concluded significant racial disparities exist within the National Can ...Written By: Katie KokolusDEC 07, 2023Immunology
Breast cancer is one of the most common cancers diagnosed in women. According to the American Cancer Society, it is ...Written By: Brian G. MorrealeOCT 13, 2023Earth & The Environment
Ally Fitts is a second-year Master’s student in the Graduate Program of Hydrologic Sciences (GPHS) at the Universi ...Written By: Laurence Tognetti, MSc
FEB 22, 2024
Immunology
The US Food and Drug Administration (FDA) recently approved a tumor-infiltrating lymphocyte (TIL) therapy referred to as
...
Written By:
Brian G. Morreale
JAN 15, 2024
Cancer
The 2014 passage of the Patient Protection and Affordable Care Act (ACA) allowed states to expand Medicaid benefits by m
...
Written By:
Katie Kokolus
JAN 08, 2024
Cancer
A recent study published in JAMA Network Open has concluded significant racial disparities exist within the National Can
...
Written By:
Katie Kokolus
DEC 07, 2023
Immunology
Breast cancer is one of the most common cancers diagnosed in women. According to the American Cancer Society, it is
...
Written By:
Brian G. Morreale
OCT 13, 2023
Earth & The Environment
Ally Fitts is a second-year Master’s student in the Graduate Program of Hydrologic Sciences (GPHS) at the Universi
...
Written By:
Laurence Tognetti, MSc
OCT 02, 2023
Cancer
The Lancet, a prominent medical journal, initiated a Commission to understand the interactions between women, power, and
...
Written By:
Katie Kokolus
AUG 19, 2023
Neuroscience
Vaccinations against tetanus and diphtheria, pneumococcus, and herpes zoster (HZ)- better known as shingles, are linked
...
Written By:
Annie Lennon
AUG 09, 2023
Space & Astronomy
NASA and private space infrastructure developer, Axiom Space, recently announced the approval for Axiom-4, which will be
...
Written By:
Laurence Tognetti, MSc
AUG 01, 2023
Clinical & Molecular DX
Genetic testing can be a very beneficial technology; it can diagnose unusual or rare disorders, and can improve the trea
...
Written By:
Carmen Leitch
-
DEC 07, 2023 | 8:00 AM
As the vast landscape of genetic oncology continues to expand, the ability to understand and utilize the full potential of this rich data becomes increasingly challenging. As a result, resea...AUG 24, 2023 | 8:30 PMC.E. CREDITS
When building your own infectious disease molecular panels there are many paths to consider. In this interview, we ask Marcus Cognetti and Dr. Ari Frenkel what approach is required to create...JUL 20, 2023 | 8:00 AM
Single-cell ATAC-seq (Assay for Transposase-Accessible Chromatin using sequencing, scATAC-seq) is a relatively new and powerful technique that allows researchers to identify open chromatin r...JUL 11, 2023 | 8:00 AM
Our understanding of cancer mechanisms, genetics and complexities continues to expand rapidly. Without a streamlined, standardized and easy to understand organizational system to keep track...JUN 22, 2023 | 11:00 AMC.E. CREDITS
When building your own infectious disease molecular panels there are many paths to consider. In this interview, we ask Marcus Cognetti and Dr. Ari Frenkel what approach is required to create...
DEC 07, 2023 | 8:00 AM
As the vast landscape of genetic oncology continues to expand, the ability to understand and utilize the full potential of this rich data becomes increasingly challenging. As a result, resea...
AUG 24, 2023 | 8:30 PM
C.E. CREDITS
When building your own infectious disease molecular panels there are many paths to consider. In this interview, we ask Marcus Cognetti and Dr. Ari Frenkel what approach is required to create...
JUL 20, 2023 | 8:00 AM
Single-cell ATAC-seq (Assay for Transposase-Accessible Chromatin using sequencing, scATAC-seq) is a relatively new and powerful technique that allows researchers to identify open chromatin r...
JUL 11, 2023 | 8:00 AM
Our understanding of cancer mechanisms, genetics and complexities continues to expand rapidly. Without a streamlined, standardized and easy to understand organizational system to keep track...
JUN 22, 2023 | 11:00 AM
C.E. CREDITS
When building your own infectious disease molecular panels there are many paths to consider. In this interview, we ask Marcus Cognetti and Dr. Ari Frenkel what approach is required to create...
JUN 21, 2023 | 6:00 AM
Globally, the hepatitis B virus is a major cause of mortality from infectious diseases. Around 250 million people suffer from chronic HBV infections, with the virus being responsible for ove...
APR 05, 2023 | 11:00 AM
C.E. CREDITS
Date: April 05, 2023 Time: 11:00am (NZDT) Date: April 04, 2023 Time: 4:00pm (PST), 7:00pm (EST), 1:00pm (CET) Polymerase chain reaction (PCR) technology-based testing method has been widely...
MAR 16, 2023 | 10:00 AM
C.E. CREDITS
Date: March 16, 2023 Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CET) On Thursday March 16, COPAN Diagnostics is pleased to release presentations given at an event held during ASM Microbe 202...
Speaker:
Caitlin Murphy, Ph.D.
, Kileen Shier, Ph.D., MBA, D(ABMM), MLS(ASCP)CM
, Susan Sharp, Ph.D., DABMM, FAAM
Sponsored By: COPAN Diagnostics
NOV 09, 2022 | 8:15 AM
In this session, researchers, clinicians, and program implementers from four countries will address the disruption in continuity of care for PLHIV amid the COVID-19 pandemic and the conseque...
Speaker:
Carlos Brites, MD, PhD
, Mandisa Dukashe, MPH, PhD(c)
, Olabanjo Okunlola Ogunsola, MBCHB, MPH, FWACP
, Dr. Cissy Kityo Mutuluuza, MBChB, M.Sc, PhD
, Obiageli Okafor, MD, DrPH, MPH, Moderator
Presented at: Clinical Diagnostics & Research Virtual Event Series 2022
Sponsored By: Thermo Fisher Scientific
Sponsored By: Thermo Fisher Scientific
-
MAR 20, 2024 | 8:30 PM PDT
The premier event in NGS education is now available on demand. Since 2020, OncomineWorld meetings have brought together thousands of scientists and professionals from around the world each y...JUL 26, 2023 | 8:00 AM PDTC.E. CREDITS
GenScript is delighted to announce its 3rd Annual Virtual Summit on Gene and Cell Engineering. This gathering will feature leaders in the life sciences from academia, pharma, and biotech, le...MAR 30, 2023 | 12:00 AM PDTC.E. CREDITS
Don’t miss the premier event in NGS education. Since 2020, OncomineWorld meetings have brought together thousands of scientists and professionals from around the world each year to adv...NOV 09, 2022 | 5:30 AM PST
Labroots is pleased to host the 13th Annual Event in the Clinical Diagnostics and Research Virtual Event Series to be held on November 9th, 2022. Registration is open now....NOV 02, 2022 | 5:30 AM PDT
Labroots invites you to the 5th Annual Event in the CRISPR Virtual Event Series! This event will continue the conversation on the abilities of CRISPR-based editing, and much more....
MAR 20, 2024
| 8:30 PM PDT
The premier event in NGS education is now available on demand. Since 2020, OncomineWorld meetings have brought together thousands of scientists and professionals from around the world each y...
JUL 26, 2023
| 8:00 AM PDT
C.E. CREDITS
GenScript is delighted to announce its 3rd Annual Virtual Summit on Gene and Cell Engineering. This gathering will feature leaders in the life sciences from academia, pharma, and biotech, le...
MAR 30, 2023
| 12:00 AM PDT
C.E. CREDITS
Don’t miss the premier event in NGS education. Since 2020, OncomineWorld meetings have brought together thousands of scientists and professionals from around the world each year to adv...
NOV 09, 2022
| 5:30 AM PST
Labroots is pleased to host the 13th Annual Event in the Clinical Diagnostics and Research Virtual Event Series to be held on November 9th, 2022. Registration is open now....
NOV 02, 2022
| 5:30 AM PDT
Labroots invites you to the 5th Annual Event in the CRISPR Virtual Event Series! This event will continue the conversation on the abilities of CRISPR-based editing, and much more....
OCT 19, 2022
| 5:30 AM PDT
Labroots announces the 2022 Coronavirus Virtual Event Series. A novel coronavirus emerged in China in 2019; it has since been dubbed COVID-19....
OCT 04, 2022
| 5:30 AM PDT
Labroots to host the 10th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Event Series! This two day event will take place on October 4-6, 2022....
SEP 21, 2022
| 5:30 AM PDT
Labroots to host the 6th Annual Event in the Cell Biology Virtual Event Series, providing an opportunity to discuss recent discoveries in biological research and more....
SEP 12 - 23 2022
Background An Agency for Healthcare Research and Quality (AHRQ) systematic review on Malnutrition In Hospitalized Adults found that individuals who are malnourished experience more hospital...